C47 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies
| Event Time: | Sunday May 5, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Neuromuscular and Clinical Neurophysiology (EMG) |
| Director(s): | Amanda Peltier MD, MS |
| Description: | Faculty will provide an overview of assessing autonomic function, including common and less common tests for diagnosis of autonomic disorders, and discuss and provide a differential diagnosis of central and peripheral causes of autonomic failure. This program complements Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments of Dysautonomia, but covers independent topics. |
| Completion Message: | Participants should be able to improve their ability to formulate a differential diagnosis of autonomic failure, appropriate tests to order to identify autonomic failure and help localize whether the disorder is central or peripheral, and be able to identify common etiologies of autonomic failure. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:05 PM | Introduction | Faculty |
| 1:05 PM - 1:35 PM | Autonomic Testing | Jeremy K. Cutsforth-Gregory MD |
| 1:35 PM - 2:05 PM | Alpha-Synucleinopathies and Autonomic Failure | Horacio C. Kaufmann MD, FAAN |
| 2:05 PM - 2:35 PM | Peripheral Autonomic Failure | Roy L. Freeman MD |
| 2:35 PM - 3:00 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Jeremy K. Cutsforth-Gregory, MD | Dr. Cutsforth-Gregory has nothing to disclose. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abide, Astellas, Aptinyx, Biogen, Chromocell, Dong-A, Ironwood, Lundbeck, MundiPharma, NeuroBo, Novartis, Pfizer, Regenacy, Toray and Theravance. Dr. Freeman has received personal compensation in an editorial capacity for Autonomic Neuroscience: Basic and Clinical. Dr. Freeman has received compensation for serving on the Board of Directors of NeuroBo. Dr. Freeman holds stock and/or stock options in NeuroBo. Dr. Freeman has received research support from Pfizer. |
| Horacio C. Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lundbeck, Theravance and Biogen. Dr. Kaufmann has received personal compensation in an editorial capacity for Clinical Autonomic Research. Dr. Kaufmann has received research support from Theravance. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 9:30 AM-11:30 AM |
|---|
|
C12 -
Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing
Tahseen Mozaffar MD, FAAN |
| 1:30 PM-3:30 PM |
|
C25 -
Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology
Tahseen Mozaffar MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C46 -
Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder)
Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN |
|
C36 -
Mastering EMG Waveform Recognition Skills in Just Two Hours!
Devon Rubin MD, FAAN |
| 1:00 PM-3:00 PM |
|
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
|
S5 -
Therapeutics in ALS and SMA
|
| 3:30 PM-5:30 PM |
|
C65 -
Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia
Amanda Peltier MD, MS |
| 11:30 AM-6:30 PM |
|---|
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C101 -
Clinical EMG I: Principles and Practice of NCS and Needle EMG
Ruple Laughlin MD, FAAN |
|
N2 -
Neuroscience in the Clinic: Interpretations of Genetic Results
Massimo Pandolfo MD, FAAN, Karen Marder MD, MPH, FAAN |
| 3:30 PM-4:45 PM |
|
S18 -
Autonomic Disorders
|
| 3:30 PM-5:30 PM |
|
C120 -
Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography
Ruple Laughlin MD, FAAN |
|
S23 -
Genetic Muscle Disorders
|
| 7:00 AM-9:00 AM |
|---|
|
C121 -
Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches
Mark Bromberg MD, PhD, FAAN |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
C131 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System
Christopher Gibbons MD, FAAN |
|
S25 -
Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
|
| 1:00 PM-5:30 PM |
|
C148 -
Skills Workshop: EMG: Basic
(Registration Required)
Holli Horak MD, FAAN |
| 3:30 PM-5:30 PM |
|
C150 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System
Christopher Gibbons MD, FAAN |
|
Presentation of the Sheila Essey Award: An Award for ALS Research
|
| 7:00 AM-9:00 AM |
|---|
|
C171 -
Child Neurology: Neuromuscular/Autoimmune Neurology
Anne Connolly MD, FAAN |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
C175 -
Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia
Laura Tormoehlen MD, FAAN |
|
N4 -
Neuroscience in the Clinic: Immunotherapies in Neurological Disease
Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN |
| 1:00 PM-5:30 PM |
|
C191 -
Skills Workshop: Neuromuscular Ultrasound
(Registration Required)
Craig Zaidman MD |
| 3:30 PM-5:30 PM |
|
C192 -
Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission
Laura Tormoehlen MD, FAAN |
|
C195 -
Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease
Madhu Soni MD, FAAN |
|
S42 -
Neuromuscular Disorders
|
| 7:00 AM-9:00 AM |
|---|
|
C205 -
Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies
David Herrmann MD, FAAN |
|
C214 -
Child Neurology: A Case-based Approach
Elaine Wirrell MD, FAAN |
| 11:30 AM-6:30 PM |
|
P5 -
Poster Session 5
|
| 1:00 PM-3:00 PM |
|
C215 -
Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies
Michelle Mauermann MD, FAAN |
| 3:30 PM-5:30 PM |
|
C229 -
Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives
Mario Saporta MD, PhD, FAAN |
|
S54 -
Motor Neuron Disease
|
| 7:00 PM-10:00 PM |
|
C237 -
Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease
Robert Pascuzzi MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C243 -
Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis
Michael Weiss MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S58 -
Therapeutics in Neuromuscular Disorders
|
| 2:00 PM-2:45 PM |
|
Consensus-Based Care Recommendations for Adults with Myotonic Dystrophy Type 1
Nicholas Johnson MD, FAAN |